Status:
COMPLETED
SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
15-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the treatment effect of montelukast 10mg on the primary endpoint of Asthma Control Questionnaire(ACQ), over a 8-week period, in persistent asthma patients with o...
Eligibility Criteria
Inclusion
- Patient is currently a nonsmoker and has been a nonsmoker for at least 1 year
- Patient with clinical evidence of mild/moderate asthma with or without allergic rhinitis
Exclusion
- Patient has been treated in an emergency room for asthma within 4 weeks or has been hospitalized for asthma within 3 months prior to visit 1
- Patient with severe asthma, upper respiratory infection, sinusitis, infectious rhinitis, non-allergic rhinitis
- Patient has any active, acute, or chronic pulmonary disorder that is documented by history, physical examination
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 17 2006
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT00445107
Start Date
November 1 2005
End Date
May 17 2006
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.